Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,278 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $387.99 | 7 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $178.74 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $159.74 | 2 | $0 (2020) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $120.05 | 4 | $0 (2021) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $72.28 | 2 | $0 (2021) |
| PFIZER INC. | $64.06 | 2 | $0 (2020) |
| Melinta Therapeutics, LLC | $50.88 | 2 | $0 (2022) |
| ABIOMED | $33.07 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $266.64 | 6 | AstraZeneca Pharmaceuticals LP ($112.18) |
| 2021 | $399.76 | 10 | AstraZeneca Pharmaceuticals LP ($157.93) |
| 2020 | $248.19 | 5 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $363.23 | 5 | E.R. Squibb & Sons, L.L.C. ($107.68) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: ANTIBIOTICS | ||||||
| 09/27/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Rare Disease | ||||||
| 09/13/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/12/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Rare Disease | ||||||
| 05/11/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: ANTIBIOTICS | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 11/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $80.05 | General |
| Category: Gastroenterology | ||||||
| 10/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Gastroenterology | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Gastroenterology | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Gastroenterology | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/27/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 04/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $58.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 220 | 224 | $215,565 | $25,001 |
| 2022 | 3 | 118 | 119 | $131,550 | $11,842 |
| 2021 | 4 | 78 | 80 | $53,552 | $5,283 |
| 2020 | 1 | 11 | 11 | $18,579 | $1,495 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 77 | 78 | $92,180 | $10,534 | 11.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 88 | 91 | $70,050 | $8,306 | 11.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 29 | 29 | $41,737 | $4,743 | 11.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 26 | 26 | $11,598 | $1,418 | 12.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 50 | 50 | $76,667 | $6,986 | 9.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 30 | 31 | $32,398 | $2,856 | 8.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 38 | 38 | $22,485 | $2,000 | 8.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 16 | 16 | $24,672 | $2,267 | 9.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 18 | 19 | $17,038 | $1,737 | 10.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 20 | 20 | $10,154 | $1,125 | 11.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 24 | 25 | $1,688 | $154.56 | 9.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 11 | 11 | $18,579 | $1,495 | 8.0% |
About Dr. David Brennan, DO
Dr. David Brennan, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2018. The National Provider Identifier (NPI) number assigned to this provider is 1013414952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brennan, DO has received a total of $1,278 in payments from pharmaceutical and medical device companies, with $266.64 received in 2022. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,278).
As a Medicare-enrolled provider, Brennan has provided services to 427 Medicare beneficiaries, totaling 434 services with total Medicare billing of $43,622. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Oklahoma City, OK
- Active Since 04/08/2018
- Last Updated 04/30/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1013414952
Products in Payments
- LOKELMA (Drug) $275.81
- ELIQUIS (Drug) $223.80
- ANDEXXA (Biological) $182.69
- GIAPREZA (Drug) $121.69
- RELISTOR (Drug) $120.05
- Andexxa (Drug) $108.23
- CROFAB (Drug) $89.32
- XARELTO (Drug) $72.28
- Kimyrsa (Drug) $50.88
- Impella (Device) $33.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117